← FDA DRUG APPROVALS

FDA ANDA · ANDA075720

METIPRANOLOL

Sponsor: SANDOZ

APPLICATION
ANDA075720
TYPE
ANDA
ORIGINAL APPROVAL
2001-08-06
LATEST ACTION
2002-12-23
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

METIPRANOLOLDiscontinued
METIPRANOLOL HYDROCHLORIDE 0.3% · SOLUTION/DROPS · OPHTHALMIC

Approval history

2002-12-23Manufacturing (CMC) · Supplement 3AP
2002-10-01Manufacturing (CMC) · Supplement 2AP
2002-03-22Manufacturing (CMC) · Supplement 1AP
2001-08-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →